Viewing Study NCT01160276



Ignite Creation Date: 2024-05-05 @ 10:41 PM
Last Modification Date: 2024-10-26 @ 10:22 AM
Study NCT ID: NCT01160276
Status: COMPLETED
Last Update Posted: 2013-04-11
First Post: 2010-07-09

Brief Title: Drug Interaction Between Colchicine and Calcineurin Inhibitors in Renal Graft Recipients
Sponsor: Assistance Publique - Hôpitaux de Paris
Organization: Assistance Publique - Hôpitaux de Paris

Study Overview

Official Title: An Open Non Randomized Comparative Study Exploring Drug Interaction Between Colchicine and Calcineurin Inhibitors in 2 Groups Ciclosporin Group and Tacrolimus Group of Renal Graft Recipients
Status: COMPLETED
Status Verified Date: 2013-04
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: COLCHINCAL
Brief Summary: Ciclosporin inhibits P-glycoprotein should increase colchicine bioavailability whereas tacrolimus should not influence colchicine disposition

This is a prospective controlled open labeled study performed in renal graft recipients comparing colchicine single dose 1mg pharmacokinetics in 14 patients treated with tacrolimus and 14 patients treated with cyclosporin
Detailed Description: Renal transplantation one year
eGFR MDRD 30mlmin
hemoglobin 11gdl
treatment with tacrolimus or cyclosporine
no previous muscular disease
no drugs interfering with P-glycoprotein or CYP3A activity or expression outcomes
colchicine AUC Cmax T12
ABCB1C3435T CYP3A5 and SLCO1B1 genotypes

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None